Chemo Brain in Cancer Patients: What Is It and How Can It Be Managed?

Slideshow

Many patients complain of "chemo brain," or a drop in cognitive function during or after receiving chemotherapy, but there are strategies to manage chemo brain, as well as research on how chemotherapy affects the brain long-term.

“Chemo brain” is a side effect of chemotherapy that affects cognitive function in cancer patients. Also known as cancer treatment–related cognitive impairment, it is often described as a decrease in mental “sharpness” before, during, and after cancer treatment, according to the American Cancer Society (ACS). The length of these effects, as well as their severity, vary. Although there is no test to diagnose the condition, nor specific treatment, some medications and coping strategies have been shown to be helpful in some patients. This slideshow discusses several strategies to manage chemo brain, as well as research on how chemotherapy affects the brain long-term.

Recent Videos
The FirstLook liquid biopsy, when used as an adjunct to low-dose CT, may help to address the unmet need of low lung cancer screening utilization.
An 80% sensitivity for lung cancer was observed with the liquid biopsy, with high sensitivity observed for early-stage disease, as well.
9 Experts are featured in this series.
9 Experts are featured in this series.
Harmonizing protocols across the health care system may bolster the feasibility of giving bispecifics to those with lymphoma in a community setting.
2 experts are featured in this series.
Patients who face smoking stigma, perceive a lack of insurance, or have other low-dose CT related concerns may benefit from blood testing for lung cancer.
9 Experts are featured in this series.
Related Content